Donald Siegel
Professor and Director, Perelman School of Medicine, University of Pennsylvania
Donald Siegel is listed as Professor and Director, Perelman School of Medicine, University of Pennsylvania. Donald is scheduled to speak at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026.
Compiled from published conference agendas; not yet confirmed by Donald. Is this you? Claim this profile.
About
Don Siegel, Ph.D., M.D. is Professor of Pathology & Laboratory Medicine and founding director of the University of Pennsylvania’s Division of Transfusion Medicine & Therapeutic Pathology. He directs Penn’s Center for Advanced Cellular Therapies which has manufactured over 3000 cell products including the first genetically modified cell therapy product approved by the FDA (tisagenlecleucel, Kymriah®) and first-in-human use of CRISPR-edited cells. Dr. Siegel’s laboratory has been funded by the NIH in the areas of immunohematology, hemostasis/thrombosis, autoimmunity, and oncology since 1992. His laboratory focuses on the discovery of recombinant antibodies relevant to transfusion medicine, benign hematology, infectious diseases, and oncology, particularly for use in the design of targeted therapies such as CAR T-cells. Since 2017, Dr. Siegel has been recognized with the RISE Award, the Dale E. Smith Memorial Award, the Tibor Greenwalt Memorial Award and Lectureship, the Emily Coo
Upcoming
2026 ASCP/CAP-ACP Annual Meeting 17 November 2026 – 22 November 2026
- General Session and ASCP Presidential Address: Innovations in CAR-T Cell Therapies for Cancer, Autoimmune Disease, and Other Maladies Speaker · 18 November 2026
Spoke alongside
People who have shared a session with Donald at events on B2DB.
- Gregory Davis Professor and Director, Forensic Division, Department of Pathology · University of Alabama at Birmingham 1 shared session